

Author: Truini Andrea Galeotti Francesca Cruccu Giorgio
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.12, Iss.15, 2011-10, pp. : 2355-2368
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Drugs Treatment of Pain in Multiple Sclerosis
Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. :








Willingness to Pay for a Treatment for Pain in Multiple Sclerosis
By Iskedjian Michael Desjardins Olivier
PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. :